程 毅君

Medicine & Life Sciences

1. Cohort Studies 100%
2. Odds Ratio 80%
3. Propensity Score 73%
4. Mortality 63%
5. Anesthesia 53%
6. Stroke 52%
7. Taiwan 52%
8. Osteoblasts 49%
9. General Anesthesia 47%
10. Retrospective Studies 45%
11. National Health Programs 41%
12. Spinal Anesthesia 40%
13. Estrogen Receptor alpha 40%
14. Chronic Renal Insufficiency 39%
15. Postoperative Nausea and Vomiting 38%
16. Population 31%
17. Randomized Controlled Trials 31%
18. Genistein 30%
19. Kidney Diseases 30%
20. Saccades 30%
21. Hospital Mortality 28%
22. Hepatocellular Carcinoma 27%
23. Chronic Kidney Failure 27%
24. Meta-Analysis 25%
25. Levobupivacaine 25%
26. Mitochondria 25%
27. Hospitalization 25%
28. Liver Cirrhosis 24%
29. Sevoflurane 24%
30. Epilepsy 23%
31. Thoracic Surgery 23%
32. Pneumonia 23%
33. Lipopolysaccharides 22%
34. Sepsis 22%
35. Parkinson Disease 21%
36. Propofol 21%
37. Entropy 20%
38. Gene Expression 20%
39. JNK Mitogen-Activated Protein Kinases 19%
40. Alveolar Epithelial Cells 19%
41. A549 Cells 19%
42. Cannula 18%
43. Desflurane 18%
44. Databases 18%
45. Caspases 18%
46. Peroxisome Proliferator-Activated Receptors 17%
47. Epidural Analgesia 17%
48. Postoperative Complications 17%
49. Mitogen-Activated Protein Kinases 17%
50. N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 16%